发明Breast tumor treatment with anti-CXCR1 compositions

pdf收藏

著录项目

申请号 US20090616579 申请日 2009年11月11日 最早公开日 2010年06月03日 所属国家/地区 美国
公开号及公开日 授权日 2015年01月27日 说明书附图
申请人 UNIV MICHIGAN (美国)  
发明人 WICHA MAX S   GINESTIER CHRISTOPHE  
优先权 US20080113458P   20081111US20090616579   20091111
专利分类号 A61K39/395   A01N37/18   A01N43/02   A01N43/16   G01N33/574   A61K31/18   A61P35/00   C12N5/095   C12Q1/04  
代理机构 代理人 Casimir Jones, S.C.  

名称及摘要

抗 cxcr1 组合物以及方法
本发明提供方法，用于治疗癌症通过服用 il8 - cxcr1 途径抑制剂（，例如，一反 cxcr1 抗体或 repertaxin ）仅或结合附加化学治疗剂，以便非 tumorigenic 以及 tumorigenic 癌症细胞患者中由于。 本发明也提供组合物以及方法，用于探以及隔离固体肿瘤干细胞中患者（，例如，基于存在 cxcr1 或 fbxo21 ）。
Breast tumor treatment with anti-CXCR1 compositions
The present invention provides methods of treating cancer by administering an IL8-CXCR1 pathway inhibitor (e.g., an anti-CXCR1 antibody or Repertaxin) alone or in combination with an additional chemotherapeutic agent such that non-tumorigenic and tumorigenic cancer cells in a subject are killed. The present invention also provides compositions and methods for detecting the presence of and isolating solid tumor stem cells in a patient (e.g., based on the presence of CXCR1 or FBXO21).

同族及引用

同族专利 （37） 引用其他专利（5） 被其他专利引用（64）

AU2009314141B2 Anti-CXCR1 compositions and methods
CA2743305C ANTI-CXCR1 COMPOSITIONS AND METHODS
WO2010056753A1 ANTI-CXCR1 COMPOSITIONS AND METHODS
US8940301B2 Breast tumor treatment with anti-CXCR1 compositions
MX2011005007A ANTI-CXCR1 COMPOSITIONS AND METHODS.
IL212822D0 ANTI-CXCR1 COMPOSITIONS AND METHODS
EP2356462B1 ANTI-CXCR1 COMPOSITIONS AND METHODS
KR20110093893A ANTI-CXCR1 COMPOSITIONS AND METHODS
CN102272599B 抗CXCR1组合物和方法
EA023466B1 METHOD OF DETECTING BREAST CANCER STEM CELLS AND USE OF CXCR1 ANTAGONISTS FOR TREATING CANCER
JP5716180B2 【Title of corresponding document：CN104634972A】 Anti-CXCR1 compositions and methods
ZA201103416B ANTI-CXCR1 COMPOSITIONS AND METHODS
JP5909783B2 ANTI-CXCR1 COMPOSITIONS AND METHODS
KR101588547B1 - ANTI-CXCR1 COMPOSITIONS AND METHODS
NZ602369A Anti-cxcr1 compositions and methods
US2015094362A1 ANTI-CXCR1 COMPOSITIONS AND METHODS
CN104634972B 抗CXCR1组合物和方法
CN104623664A 抗CXCR1组合物和方法
US9606124B2 Methods of detecting and treating stem-cell containing solid tumors
KR20150065930A ANTI-CXCR1 COMPOSITIONS AND METHODS
HK1161350A1 ANTI-CXCR1 COMPOSITIONS AND METHODS CXCR1
HK1206421A1 ANTI-CXCR1 COMPOSITIONS AND METHODS CXCR1
HK1206256A1 ANTI-CXCR1 COMPOSITIONS AND METHODS CXCR1
NZ625440A Anti-cxcr1 compositions and methods
JP2016065082A ANTI-CXCR1 COMPOSITIONS AND METHODS
DK2356462T3 【Title of corresponding document：us8940301B2】
LT2356462T ANTI-CXCR1 COMPOSITIONS AND METHODS
PT2356462T ANTI-CXCR1 COMPOSITIONS AND METHODS
EP3153862A1 ANTI-CXCR1 COMPOSITIONS AND METHODS
HRP20170463T1 ANTI-CXCR1 COMPOSITIONS AND METHODS
SG10201701954QA ANTI-CXCR1 COMPOSITIONS AND METHODS
SI2356462T1 ANTI-CXCR1 COMPOSITIONS AND METHODS
ES2623128T3 【Title of corresponding document：ep3153862A1】
PL2356462T3 ANTI-CXCR1 COMPOSITIONS AND METHODS
RS55784B1 ANTI-CXCR1 COMPOSITIONS AND METHODS
HUE032623T2 ANTI-CXCR1 COMPOSITIONS AND METHODS
CY1118933T1 【Title of corresponding document：ep3153862A1】
磺酰胺类化合物的制备及其应用
芳香杂环磺酰胺类化合物的制备及其应用
作为对表皮生长因子受体治疗剂治疗的响应的预测物的CXCR1
INHIBITION OF INTERLEUKIN-8 AND/OR ITS RECEPTOR CXCR1 IN THE TREATMENT OF HER2/HER3-OVEREXPRESSING BREAST CANCER
Methods of detecting and treating stem-cell containing solid tumors
ISOLATION AND USE OF SOLID TUMOR STEM CELLS
用于乳腺癌的预后的方法和试剂盒
Trapped key mechanism
Method and composition for cancer detection in humans
Recombinant immunoglobin preparations
Apparatus and method for performing immunoassays
Single polypeptide chain binding molecules
Method of making a brush
Directed evolution of novel binding proteins
Intermediates for conjugation of polypeptides with high molecular weight polyalkylene glycols
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
Transgenic non-human animals capable of producing heterologous antibodies
Ransgenic non-human animals for producing heterologous antibodies
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
Automated continuous and random access analytical system
Immunoassays for prostate specific antigen
Fluorescent energy transfer immunoassay
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
Production of chimeric antibodies - a combinatorial approach
Production of antibodies from transgenic animals
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
Transgenic non-human animals for producing heterologous antibodies
Method for making heteromultimeric polypeptides
Low pH hydrophobic interaction chromatography for antibody purification
Humanized antibodies and methods for making them
Immunoassays for prostate specific antigen
Adjuvant incorporation into antigen carrying cells: compositions and methods
Implanted tumor cells for the prevention and treatment of cancer
Humanized immunoglobulins
Methods for fabricating microarrays of biological samples
Humanized immunoglobulins and methods of making the same
Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
Fluorescence polarization immunoassay diagnostic method
Fluorometric detection using visible light
Automated immunoassay analyzer
Isolation and use of solid tumor stem cells
Hybrid antibodies and uses thereof
Isolation and use of solid tumor stem cells
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
Anti-interleukin 8 therapy for tumor osteolysis
Methods and compositions for treating and preventing tumors
IL-8 receptor antagonists
Determining the capability of a test compound to affect solid tumor stem cells
ALDH1 As A Cancer Stem Cell Marker
Breast tumor treatment with anti-CXCR1 compositions
ANTI-CXCR1 COMPOSITIONS AND METHODS
INTERACTION TRAP SYSTEM FOR ISOLATING NOVEL PROTEINS
PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS
ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH CXC CHEMOKINE RECEPTOR 1 (CXCR1)
COMPOSITIONS AND METHODS FOR CHARACTERIZING, REGULATING, DIAGNOSING, AND TREATING CANCER
CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS
COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
ALDEHYDE DEHYDROGENASE 1(ALDH1) AS A CANCER STEM CELL MARKER
COLON STEM CELLS ASSOCIATED WITH COLITIS AND COLORECTAL CANCER AND METHODS OF USE
ANTI-CXCR1 COMPOSITIONS AND METHODS

法律状态历史( 到官方网站查询 )

2009年11月18日 us_as 转让（新专利权人: NATIONAL INSTITUTES OF HEALTH (NIH),U.S. DEPT. OF
更多信息: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF MICHIGAN;REEL/FRAME:023536/0383
生效日期: 20091117）
2010年02月01日 us_as 转让（新专利权人: THE REGENTS OF THE UNIVERSITY OF MICHIGAN,MICHIGAN
更多信息: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WICHA,MAX S.;GINESTIER,CHRISTOPHE;REEL/FRAME:023877/0004
生效日期: 20081112）
2010年02月01日 us_as 转让（新专利权人: THE REGENTS OF THE UNIVERSITY OF MICHIGAN,MICHIGA
更多信息: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WICHA,MAX S.;GINESTIER,CHRISTOPHE;REEL/FRAME:023877/0004
生效日期: 20081112）
2010年05月06日 us_as 转让（新专利权人: NATIONAL INSTITUTES OF HEALTH (NIH),U.S. DEPT. OF
更多信息: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF MICHIGAN;REEL/FRAME:024344/0086
生效日期: 20091117）
2010年05月06日 us_as 转让（新专利权人: NATIONAL INSTITUTES OF HEALTH (NIH),U.S. DEPT. OF
更多信息: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF MICHIGAN;REEL/FRAME:024344/0198
生效日期: 20091117）
2014年12月10日 us_sulp 逾期付款的附加费（）
2015年05月05日 us_cc 更正的证书（）

更新记录

2014年06月20日